Sulfobutyl ether β-Cyclodextrin-based supramolecular nanoparticles: pH-sensitive nanocarriers for the sustained release of anti-tumor drugs

Posted by

In this work, pH-responsive nanoparticles based on sulfobutyl ether-β-CD (SBE7-β-CD) and cetylbenzyldimethylammonium chloride (HDBAC) were designed and prepared. The obtained nanoparticles showed assembly and disassembly behaviors with the pH alternating between 10.0 and 2.0, and were adopted to encapsulate and release the anti-tumor drug celastrol (CSL). Moreover, CSL-loaded nanoparticles exhibited sustained release action for 82 h, which suggests that it may show potential in improving the therapeutic effects. In cell experiments, CSL-loaded nanoparticles displayed fewer cytotoxic effects on healthy cells, while significant cytotoxicity on five human cancer cells. Notably, CSL-loaded nanoparticles showed a higher apoptosis rate on liver cancer SMMC-7721cells than free CSL.

Li, B.L., Wang, C.L., Wang, O., Yang, J.M., Chi, S.M., Chen, J.C., Zhang, J., Zhao, Y. : β-Cyclodextrin-based supramolecular nanoparticles: pH-sensitive nanocarriers for the sustained release of anti-tumor drugs. New J. Chem., 2022,46, 21823-21833. DOI: https://doi.org/10.1039/D2NJ02894H

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.